Institut national de santé publique du Québec, 2400 d'Estimauville, Québec, Québec, Canada.
Vaccine. 2011 Apr 12;29(17):3177-82. doi: 10.1016/j.vaccine.2011.02.044. Epub 2011 Mar 2.
Rotavirus is the leading cause of dehydration and hospitalization due to gastroenteritis (GE) in young children. Almost all children are affected by the age of 5 years. Two safe and effective rotavirus vaccines are available for clinical use in Canada. In the context where rotavirus vaccination is recommended, but not publicly funded, we have assessed paediatricians' knowledge, attitudes and beliefs (KAB) regarding rotavirus disease and its prevention by vaccination. A self-administered anonymous questionnaire based upon the Health Belief Model and the Analytical framework for immunization programs was mailed to all 1852 Canadian paediatricians. The response rate was 50%. The majority of respondents rated consequences of rotavirus infection for young patients as moderate. Sixty-six percent considered that rotavirus disease occur frequently without vaccination and 62% estimated that the disease generates a significant economic burden. Sixty-nine percent of respondents considered rotavirus vaccines to be safe and 61%, to be effective. The reduction of severe GE cases was seen as the main benefit of rotavirus vaccination, while the risk of adverse events was the principal perceived barrier. Fifty-three percent (53%) indicated a strong intention to recommend rotavirus vaccines. In multivariate analysis, main determinant of paediatricians' intention to recommend rotavirus vaccines was the perceived health and economic burden of rotavirus diseases (partial R(2)=0.49, p<0.0001). More than half of surveyed paediatricians were willing to recommend rotavirus vaccines to their patients, but the proportion of respondents who had a strong intention to do so remains low when compared to several other new vaccines. As with other new vaccines, rotavirus vaccine uptake risks to remain low in Canada as long as it is not publicly funded.
轮状病毒是导致婴幼儿肠胃炎(GE)脱水和住院的主要原因。几乎所有的孩子在 5 岁之前都会受到影响。加拿大有两种安全有效的轮状病毒疫苗可供临床使用。在轮状病毒疫苗接种被推荐但未得到公共资金支持的情况下,我们评估了儿科医生对轮状病毒疾病及其疫苗预防的知识、态度和信念(KAB)。我们向所有 1852 名加拿大儿科医生邮寄了一份基于健康信念模型和免疫规划分析框架的自我管理匿名问卷。回复率为 50%。大多数受访者认为轮状病毒感染对年轻患者的后果是中度的。66%的人认为轮状病毒疾病在没有接种疫苗的情况下经常发生,62%的人估计这种疾病会带来巨大的经济负担。69%的受访者认为轮状病毒疫苗是安全的,61%的人认为轮状病毒疫苗是有效的。减少严重 GE 病例被视为轮状病毒疫苗接种的主要益处,而不良事件的风险是主要的感知障碍。53%(53%)表示强烈愿意推荐轮状病毒疫苗。在多变量分析中,儿科医生推荐轮状病毒疫苗的主要决定因素是轮状病毒疾病的健康和经济负担(部分 R(2)=0.49,p<0.0001)。超过一半的被调查儿科医生愿意向他们的患者推荐轮状病毒疫苗,但与其他几种新疫苗相比,愿意强烈推荐轮状病毒疫苗的受访者比例仍然较低。与其他新疫苗一样,只要轮状病毒疫苗不得到公共资金支持,加拿大的疫苗接种率仍有很低的风险。